IHH has launched an internal Innovation Portal to recognise and facilitate sharing of innovation projects, connect staff with relevant and interesting digital health companies, and provide access to relevant research and market reports. Highlights of this portal:
1. Innovation Portfolio Companies - IHH is a strategic investor in early stage innovative digital health companies. Staff can take a look at what our portfolio companies can offer and how we are working with them.
2. Proprietary Start-Up Database - Enable IHH staff to look for relevant technologies or solutions.
3. Featured Innovations – Spotlights innovation projects across our markets.
We hope this portal will help our staff and various functions enhance IHH’s clinical, operational and service capabilities to deliver even better patient care. Through Innovation, we can achieve and deliver “Care. For Good”.
If you are a digital health company interested in connecting with IHH, you can email us at [email protected].
Related Stories
Project Renaissance at Mount Elizabeth Hospital, Where Legacy Meets the Future of Care
Over a span of 1,095 days, Project Renaissance marked a significant chapter in the evolution of Mount Elizabeth Hospital, one of Singapore’s most established private healthcare institutions. Conceived as a strategic transformation rather than a conventional refurbishment, the initiative sought to position the hospital for the demands of a rapidly changing healthcare landscape.
IHH Healthcare North Asia Strengthens Integrated Care Through Strategic Partnership
2026 IHH Global Town Hall: Building a Future-ready Workforce
'Building a Future-ready Workforce' took centre stage at IHH Healthcare's 2026 Global Town Hall on 9 February, bringing colleagues together across 10 countries in a truly hybrid experience that underscored the group's commitment to future-proof healthcare.
IHH Malaysia Partners Libyan Government for Medical Referrals
IHH Healthcare Malaysia signed a Memorandum of Understanding (MOU) with The Government of Libya on 9 February, establishing a structured medical referral pathway for Libyan civil servants requiring specialist treatment at 18 hospitals across IHH’s Malaysian network.
Agilus Diagnostics Expands Access to Next-Generation Precision Genomics
Agilus Diagnostics, a subsidiary of Fortis Healthcare, has installed the Illumina NovaSeq X sequencing platform at its Mumbai reference laboratory, marking a major step forward for precision genomics in India.
